| Name | Title | Contact Details |
|---|
Empower innovation in your business with TEAMs intelligent IT solutions, including custom development and software solutions, RPA, Microsoft services, and much more!
Juventas Therapeutics is a private clinical-stage company developing novel therapies for ischemic cardiovascular disease. The company`s lead product` JVS-100` is a non-viral plasmid that encodes for stromal cell-derived factor-1 (SDF-1). SDF-1 has been shown to significantly increase end-organ function following tissue injury by promoting cell survival` recruiting endogenous stem cells to the damaged region` and promoting new blood vessel growth. The SDF-1 repair pathway is well conserved throughout end-organ systems providing the opportunity to impact a broad range of diseases. Target cardiovascular clinical indications address large markets with high unmet medical need and significant market potential. Juventas is currently enrolling multiple clinical trials to test therapy efficacy in heart failure and critical limb ischemia patients.
UnlockOKR is a simple, affordable and a comprehensive #OKRTool that helps organizations of any size improve their business performance - https://t.co/XJ4ZMJMU8Y
GGWP is a company that uses machine learning and big data to solve challenging and fun problems in gaming. They also offer IT services and consulting.
Providing internet marketing, online advertising, web development, lead gen, search engine optimization, e-commerce management, order fulfillment and consulting services since 2008.